Davita Healthcare Partners Inc (DVA)

$198.10 -2.44 (-1.22%)
Market Cap 12.77B
Revenue (ttm) 13.64B
Net Income (ttm) 746.80M
EPS (ttm) N/A
PE Ratio 16.94
Forward PE 13.18
Profit Margin 5.47%
Debt to Equity Ratio -22.49
Volume 586,295
Avg Vol 879,160
Day's Range N/A - N/A
Shares Out 64.20M
Stochastic %K 96%
Beta 0.84
Analysts Sell
Price Target $190.50

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administ...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 720 631 2100
Address:
2000 16th Street, Denver, United States
MGAP
MGAP Aug. 22 at 12:30 PM
$DVA on point https://youtu.be/p6fG4LunjhU?is=RJmgDngfG4v_1zLr
0 · Reply
MGAP
MGAP Aug. 21 at 6:37 PM
$DVA if you know … you know
1 · Reply
chartistmind
chartistmind Aug. 21 at 4:47 PM
$DVA added, broke as f
0 · Reply
MGAP
MGAP Aug. 21 at 3:13 PM
$DVA
0 · Reply
MGAP
MGAP Aug. 21 at 3:13 PM
$DVA hiiii
0 · Reply
Noname2022
Noname2022 Aug. 21 at 1:45 PM
The key here: CMS is proposing to reset the dialysis BSI benchmark from 2014 to 2023 data, creating a much more current standard against which facilities will be judged potentially raising the bar for operators that fail to keep improving bloodstream-infection prevention. $CRMD $FMS $DVA https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2027-end-stage-renal-disease-esrd-prospective-payment-system-proposed-rule
1 · Reply
Noname2022
Noname2022 Aug. 21 at 1:35 PM
$CRMD $DVA $FMS In 2023 NHSN data, CVCs represented just 31.9% of dialysis exposure (1,618,379 ÷ 5,069,759 patient-months), yet accounted for 70.0% of all bloodstream infections (9,720 ÷ 13,877 BSIs). https://www.cdc.gov/nhsn/pdfs/ltc/4-2025-Annual-Training-HAI-Dialysis-Dailysis-508c.pdf?
1 · Reply
MGAP
MGAP Aug. 21 at 2:21 AM
$DVA https://youtu.be/RxirJvNrrC8?is=MHvProqyfA6C_uu2
0 · Reply
Sleepy_Don
Sleepy_Don Aug. 21 at 12:44 AM
$BTC.X $DJT $DVA $MSTR You mean runs. 💩
0 · Reply
BoilingPoint
BoilingPoint Aug. 21 at 12:38 AM
$BTC.X $DJT $DVA $MSTR Have fun at your monster truck shows and I will be in the Caribbean with your money….
0 · Reply
Latest News on DVA
DaVita price target lowered to $215 from $250 at Truist

2026-08-07T14:10:49.000Z - 16 days ago

DaVita price target lowered to $215 from $250 at Truist

DaVita upgraded to Buy from Hold at TD Cowen

2026-08-07T09:35:19.000Z - 16 days ago

DaVita upgraded to Buy from Hold at TD Cowen

DaVita price target raised to $265 from $220 at Deutsche Bank

2026-08-05T13:49:26.000Z - 18 days ago

DaVita price target raised to $265 from $220 at Deutsche Bank

DaVita price target raised to $170 from $145 at BofA

2026-08-05T13:42:38.000Z - 18 days ago

DaVita price target raised to $170 from $145 at BofA

DaVita price target raised to $224 from $218 at Barclays

2026-08-05T09:10:30.000Z - 18 days ago

DaVita price target raised to $224 from $218 at Barclays

DaVita flags lower revenue per treatment, reaffirms annual forecast

Aug 4, 2026, 6:45 PM EDT - 19 days ago

DaVita flags lower revenue per treatment, reaffirms annual forecast

DaVita Earnings Call Transcript: Q2 2026

Aug 4, 2026, 5:00 PM EDT - 19 days ago

DaVita Earnings Call Transcript: Q2 2026

DaVita Earnings release: Q2 2026

Aug 4, 2026, 5:00 PM EDT - 19 days ago

DaVita Earnings release: Q2 2026

DaVita Quarterly report: Q2 2026

Aug 4, 2026, 5:00 PM EDT - 19 days ago

DaVita Quarterly report: Q2 2026

DaVita reports Q2 EPS $4.02, consensus $3.88

2026-08-04T20:18:57.000Z - 19 days ago

DaVita reports Q2 EPS $4.02, consensus $3.88

DaVita sees FY26 adjusted EPS $14.10-$15.20, consensus $14.88

2026-08-04T20:17:52.000Z - 19 days ago

DaVita sees FY26 adjusted EPS $14.10-$15.20, consensus $14.88

DaVita Inc. 2nd Quarter 2026 Results

Aug 4, 2026, 4:05 PM EDT - 19 days ago

DaVita Inc. 2nd Quarter 2026 Results

DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call

Jul 21, 2026, 5:00 PM EDT - 4 weeks ago

DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call

DaVita price target raised to $250 from $205 at Truist

2026-07-14T11:50:38.000Z - 5 weeks ago

DaVita price target raised to $250 from $205 at Truist

DaVita price target raised to $270 from $235 at UBS

2026-07-10T10:20:39.000Z - 6 weeks ago

DaVita price target raised to $270 from $235 at UBS

DaVita price target raised to $218 from $194 at Barclays

2026-07-08T10:25:50.000Z - 6 weeks ago

DaVita price target raised to $218 from $194 at Barclays

DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals

May 18, 2026, 3:00 PM EDT - 3 months ago

DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals

DaVita Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 5:20 PM EDT - 3 months ago

DaVita Transcript: Bank of America Global Healthcare Conference 2026

DaVita price target raised to $201 from $144 at TD Cowen

2026-05-11T14:28:21.000Z - 3 months ago

DaVita price target raised to $201 from $144 at TD Cowen

DaVita price target raised to $205 from $158 at Truist

2026-05-08T11:57:34.000Z - 3 months ago

DaVita price target raised to $205 from $158 at Truist

DaVita price target raised to $235 from $190 at UBS

2026-05-07T13:29:05.000Z - 3 months ago

DaVita price target raised to $235 from $190 at UBS

DaVita price target raised to $194 from $158 at Barclays

2026-05-07T11:44:30.000Z - 3 months ago

DaVita price target raised to $194 from $158 at Barclays

DaVita upgraded to Buy from Hold at Deutsche Bank

2026-05-07T10:41:29.000Z - 3 months ago

DaVita upgraded to Buy from Hold at Deutsche Bank

DaVita rises 19.6%

2026-05-07T03:38:03.000Z - 3 months ago

DaVita rises 19.6%

DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference

May 6, 2026, 6:01 PM EDT - 3 months ago

DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference

DaVita lifts annual profit forecast on strong demand for dialysis services

May 5, 2026, 5:31 PM EDT - 3 months ago

DaVita lifts annual profit forecast on strong demand for dialysis services

DaVita Earnings Call Transcript: Q1 2026

May 5, 2026, 5:00 PM EDT - 3 months ago

DaVita Earnings Call Transcript: Q1 2026

DaVita Earnings release: Q1 2026

May 5, 2026, 5:00 PM EDT - 3 months ago

DaVita Earnings release: Q1 2026

DaVita Quarterly report: Q1 2026

May 5, 2026, 5:00 PM EDT - 3 months ago

DaVita Quarterly report: Q1 2026

DaVita Inc. 1st Quarter 2026 Results

May 5, 2026, 4:05 PM EDT - 3 months ago

DaVita Inc. 1st Quarter 2026 Results

Honeywell Announces Board of Directors for Honeywell Aerospace

Apr 28, 2026, 7:00 AM EDT - 4 months ago

Honeywell Announces Board of Directors for Honeywell Aerospace

HON

DaVita Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

DaVita Proxy statement: Proxy filing

DaVita Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

DaVita Proxy statement: Proxy filing

DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call

Apr 20, 2026, 2:06 PM EDT - 4 months ago

DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call

DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement

Mar 18, 2026, 3:00 PM EDT - 5 months ago

DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement

R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease

Mar 17, 2026, 7:00 AM EDT - 5 months ago

R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease

DaVita Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 11:50 AM EST - 6 months ago

DaVita Transcript: TD Cowen 46th Annual Health Care Conference

DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference

Feb 24, 2026, 2:00 PM EST - 6 months ago

DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference

20 stocks of companies that delivered a double dose of growth this earnings season

Feb 11, 2026, 10:45 AM EST - 6 months ago

20 stocks of companies that delivered a double dose of growth this earnings season

APH BA CAH FICO GLW GOOG GOOGL

TER Quarterly Sales Top $1B, DVA & PEP Beat Earnings

Feb 3, 2026, 11:00 AM EST - 7 months ago

TER Quarterly Sales Top $1B, DVA & PEP Beat Earnings

PEP TER

DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump

Feb 2, 2026, 5:06 PM EST - 7 months ago

DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump

DaVita Earnings Call Transcript: Q4 2025

Feb 2, 2026, 5:00 PM EST - 7 months ago

DaVita Earnings Call Transcript: Q4 2025

DaVita Annual report: Q4 2025

Feb 2, 2026, 5:00 PM EST - 7 months ago

DaVita Annual report: Q4 2025

DaVita Earnings release: Q4 2025

Feb 2, 2026, 5:00 PM EST - 7 months ago

DaVita Earnings release: Q4 2025

DaVita Annual report: Q4 2025

Feb 2, 2026, 5:00 PM EST - 7 months ago

DaVita Annual report: Q4 2025

DaVita Inc. 4th Quarter 2025 Results

Feb 2, 2026, 4:05 PM EST - 7 months ago

DaVita Inc. 4th Quarter 2025 Results

DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call

Jan 21, 2026, 10:00 AM EST - 7 months ago

DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call

DaVita Names New Leaders to Accelerate Care Transformation

Dec 11, 2025, 8:00 AM EST - 9 months ago

DaVita Names New Leaders to Accelerate Care Transformation

DaVita Transcript: Wolfe Research Healthcare Conference 2025

Nov 17, 2025, 11:20 AM EST - 9 months ago

DaVita Transcript: Wolfe Research Healthcare Conference 2025

DaVita Inc. to Participate in Fireside Chat with Wolfe Research

Nov 14, 2025, 4:16 PM EST - 10 months ago

DaVita Inc. to Participate in Fireside Chat with Wolfe Research

DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025

DaVita misses quarterly profit estimates on rising costs, lower volumes

Oct 29, 2025, 5:32 PM EDT - 10 months ago

DaVita misses quarterly profit estimates on rising costs, lower volumes

DaVita Earnings Call Transcript: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 10 months ago

DaVita Earnings Call Transcript: Q3 2025

DaVita Quarterly report: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 10 months ago

DaVita Quarterly report: Q3 2025

DaVita Earnings release: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 10 months ago

DaVita Earnings release: Q3 2025

DaVita Inc. 3rd Quarter 2025 Results

Oct 29, 2025, 4:05 PM EDT - 10 months ago

DaVita Inc. 3rd Quarter 2025 Results

DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives

Oct 20, 2025, 8:00 AM EDT - 10 months ago

DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives

DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call

Oct 13, 2025, 2:00 PM EDT - 11 months ago

DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call

DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care

Aug 27, 2025, 8:00 AM EDT - 1 year ago

DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care

Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows

Aug 21, 2025, 5:59 PM EDT - 1 year ago

Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows

DaVita beats quarterly profit on steady demand for dialysis services

Aug 5, 2025, 5:15 PM EDT - 1 year ago

DaVita beats quarterly profit on steady demand for dialysis services

DaVita Earnings Call Transcript: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 1 year ago

DaVita Earnings Call Transcript: Q2 2025

DaVita Quarterly report: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 1 year ago

DaVita Quarterly report: Q2 2025

DaVita Earnings release: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 1 year ago

DaVita Earnings release: Q2 2025

DaVita Inc. 2nd Quarter 2025 Results

Aug 5, 2025, 4:05 PM EDT - 1 year ago

DaVita Inc. 2nd Quarter 2025 Results

DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call

Jul 17, 2025, 5:37 PM EDT - 1 year ago

DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call

20 stocks primed for rapid growth while trading at half of Nvidia's valuation

Jun 2, 2025, 12:15 PM EDT - 1 year ago

20 stocks primed for rapid growth while trading at half of Nvidia's valuation

AIG APTV BALL CTRA DELL ELV EQT

DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

May 30, 2025, 2:35 PM EDT - 1 year ago

DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

May 20, 2025, 4:42 PM EDT - 1 year ago

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

May 20, 2025, 9:05 AM EDT - 1 year ago

DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

DaVita Inc. Announces Offering of $750 Million Senior Notes

May 20, 2025, 8:51 AM EDT - 1 year ago

DaVita Inc. Announces Offering of $750 Million Senior Notes

DaVita beats quarterly profit estimates amid stable demand for dialysis services

May 12, 2025, 5:37 PM EDT - 1 year ago

DaVita beats quarterly profit estimates amid stable demand for dialysis services

DaVita Earnings Call Transcript: Q1 2025

May 12, 2025, 5:00 PM EDT - 1 year ago

DaVita Earnings Call Transcript: Q1 2025

DaVita Quarterly report: Q1 2025

May 12, 2025, 5:00 PM EDT - 1 year ago

DaVita Quarterly report: Q1 2025

DaVita Earnings release: Q1 2025

May 12, 2025, 5:00 PM EDT - 1 year ago

DaVita Earnings release: Q1 2025

DaVita First-Quarter 2025 Financial Results: Just the Numbers

May 12, 2025, 4:51 PM EDT - 1 year ago

DaVita First-Quarter 2025 Financial Results: Just the Numbers

DaVita Inc. 1st Quarter 2025 Results

May 12, 2025, 4:05 PM EDT - 1 year ago

DaVita Inc. 1st Quarter 2025 Results

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

Apr 30, 2025, 11:00 AM EDT - 1 year ago

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

DaVita Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

DaVita Proxy statement: Proxy Filing

DaVita Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

DaVita Proxy statement: Proxy Filing

DaVita Says Ransomware Attack Affecting Some Operations

Apr 14, 2025, 7:35 AM EDT - 1 year ago

DaVita Says Ransomware Attack Affecting Some Operations

Dialysis firm DaVita hit by ransomware attack

Apr 14, 2025, 7:33 AM EDT - 1 year ago

Dialysis firm DaVita hit by ransomware attack

These 15 stocks are the most profitable companies in the S&P 500

Mar 31, 2025, 7:35 AM EDT - 1 year ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX COR

DaVita Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 11, 2025, 9:00 AM EDT - 1 year ago

DaVita Transcript: Barclays 27th Annual Global Healthcare Conference

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

Mar 6, 2025, 10:00 AM EST - 1 year ago

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

Feb 27, 2025, 9:00 AM EST - 1 year ago

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

Berkshire Hathaway sells another 750,000 DaVita shares

Feb 19, 2025, 8:05 PM EST - 1 year ago

Berkshire Hathaway sells another 750,000 DaVita shares

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Feb 14, 2025, 1:01 PM EST - 1 year ago

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

Feb 14, 2025, 8:16 AM EST - 1 year ago

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

Berkshire sells some DaVita shares, cuts stake to 45%

Feb 13, 2025, 8:13 PM EST - 1 year ago

Berkshire sells some DaVita shares, cuts stake to 45%

DaVita forecasts 2025 profit below estimates, shares plummet

Feb 13, 2025, 6:07 PM EST - 1 year ago

DaVita forecasts 2025 profit below estimates, shares plummet

DaVita Earnings Call Transcript: Q4 2024

Feb 13, 2025, 5:00 PM EST - 1 year ago

DaVita Earnings Call Transcript: Q4 2024

DaVita Annual report: Q4 2024

Feb 13, 2025, 5:00 PM EST - 1 year ago

DaVita Annual report: Q4 2024

DaVita Earnings release: Q4 2024

Feb 13, 2025, 5:00 PM EST - 1 year ago

DaVita Earnings release: Q4 2024

DaVita Inc. 4th Quarter 2024 Results

Feb 13, 2025, 4:05 PM EST - 1 year ago

DaVita Inc. 4th Quarter 2024 Results

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

Jan 30, 2025, 11:55 AM EST - 1 year ago

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

MGAP
MGAP Aug. 22 at 12:30 PM
$DVA on point https://youtu.be/p6fG4LunjhU?is=RJmgDngfG4v_1zLr
0 · Reply
MGAP
MGAP Aug. 21 at 6:37 PM
$DVA if you know … you know
1 · Reply
chartistmind
chartistmind Aug. 21 at 4:47 PM
$DVA added, broke as f
0 · Reply
MGAP
MGAP Aug. 21 at 3:13 PM
$DVA
0 · Reply
MGAP
MGAP Aug. 21 at 3:13 PM
$DVA hiiii
0 · Reply
Noname2022
Noname2022 Aug. 21 at 1:45 PM
The key here: CMS is proposing to reset the dialysis BSI benchmark from 2014 to 2023 data, creating a much more current standard against which facilities will be judged potentially raising the bar for operators that fail to keep improving bloodstream-infection prevention. $CRMD $FMS $DVA https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2027-end-stage-renal-disease-esrd-prospective-payment-system-proposed-rule
1 · Reply
Noname2022
Noname2022 Aug. 21 at 1:35 PM
$CRMD $DVA $FMS In 2023 NHSN data, CVCs represented just 31.9% of dialysis exposure (1,618,379 ÷ 5,069,759 patient-months), yet accounted for 70.0% of all bloodstream infections (9,720 ÷ 13,877 BSIs). https://www.cdc.gov/nhsn/pdfs/ltc/4-2025-Annual-Training-HAI-Dialysis-Dailysis-508c.pdf?
1 · Reply
MGAP
MGAP Aug. 21 at 2:21 AM
$DVA https://youtu.be/RxirJvNrrC8?is=MHvProqyfA6C_uu2
0 · Reply
Sleepy_Don
Sleepy_Don Aug. 21 at 12:44 AM
$BTC.X $DJT $DVA $MSTR You mean runs. 💩
0 · Reply
BoilingPoint
BoilingPoint Aug. 21 at 12:38 AM
$BTC.X $DJT $DVA $MSTR Have fun at your monster truck shows and I will be in the Caribbean with your money….
0 · Reply
extremeinvestor
extremeinvestor Aug. 21 at 12:36 AM
$BTC.X $DJT $DVA $MSTR
3 · Reply
PaddyOoohhYeah
PaddyOoohhYeah Aug. 21 at 12:33 AM
$MSTR $DJT $BTC.X $DVA
0 · Reply
BoilingPoint
BoilingPoint Aug. 21 at 12:32 AM
$BTC.X $DJT $DVA $MSTR You are so angry at Trump and Republicans you are missing the run of a lifetime!!!!!
0 · Reply
HydrogenH2
HydrogenH2 Aug. 21 at 12:31 AM
$MSTR $DJT $BTC.X $DVA I'm not mad...lol It'S MAGA story line !! rinse & repeat.... all this with Trump's meme coins, crypto scam,DJT... Bible, hat, watch, name it... lol 😜🤪😝
1 · Reply
Bazziggr
Bazziggr Aug. 21 at 12:30 AM
$DVA $170?
0 · Reply
BoilingPoint
BoilingPoint Aug. 21 at 12:26 AM
$BTC.X $DJT $DVA $MSTR Love Mad Bears!!!
0 · Reply
HydrogenH2
HydrogenH2 Aug. 21 at 12:25 AM
$MSTR $DJT $BTC.X $DVA Trust me if it's MAGA... it's dumb !!
1 · Reply
HydrogenH2
HydrogenH2 Aug. 21 at 12:16 AM
$MSTR $DJT $BTC.X Very soon MAGA will start selling the 2nd kidney for this scam !! Oups !! No wonder Buffet bought some $DVA lol 😜🤪😝
0 · Reply
MGAP
MGAP Aug. 19 at 10:12 PM
$DVA in
0 · Reply
Noname2022
Noname2022 Aug. 18 at 1:52 AM
$CRMD $DVA $FMS DaVita introduced ClearGuard HD in May 2019 as “standard of care for CVC patients.” Now CorMedix says upcoming data “will highlight the demonstrated efficacy of DefenCath when used in combination with chlorhexidine antimicrobial caps.” If durable Medicare Advantage reimbursement is secured in early 2027, does DefenCath eventually follow ClearGuard’s path at DaVita? https://stockanalysis.com/stocks/crmd/transcripts/669135-q2-2026/ https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3442083
1 · Reply
wolfofwestloop
wolfofwestloop Aug. 17 at 9:47 AM
$CRMD Joe's excitement level on the ER call after announcing they just signed an agreement with $DVA and they have $250M in cash on hand.
0 · Reply
Noname2022
Noname2022 Aug. 15 at 3:43 PM
$CRMD $DVA
1 · Reply